The report provides a detailed analysis essential for establishing a 5-Fluorouracil production plant. It encompasses all critical aspects necessary for 5-Fluorouracil production, including the cost of 5-Fluorouracil production, 5-Fluorouracil plant cost, 5-Fluorouracil production costs, and the overall 5-Fluorouracil production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a 5-Fluorouracil production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
5-Fluorouracil is an important anticancer medicine widely used in hospitals and oncology centres. It is commonly used as a drug in chemotherapy plans for cancers of the colon, stomach, pancreas, and breast. It is utilised as a major ingredient in many chemotherapy regimens because it slows the growth of cancer cells and helps shrink tumours. The drug is also used in topical formulations to treat certain skin conditions, including actinic keratosis, precancerous lesions, and some early-stage skin cancers. Additionally, 5-Fluorouracil is applied in research settings to study cancer cell behaviour and test new therapies. Its versatility across different treatment methods makes it a valuable component in modern cancer management.
The market for 5-Fluorouracil is primarily driven by its application as a major chemotherapy drug in cancer treatment centres for managing various solid tumours, which fuels its demand in the medical sector. Its application in the treatment of cancers of the colon, stomach, pancreas, breast, and certain skin conditions strongly contributes to its demand across oncology care and pharmaceutical industries. Its role in combination therapy in hospitals and cancer treatment centres that rely on multi-drug regimens for better results further fuels its demand in the pharmaceutical and healthcare industries.
Its usage in topical formulations for managing actinic keratosis and certain early-stage skin cancers also boosts its relevance in dermatology. Advances in production methods, dependable suppliers, responsible sourcing, and smooth global distribution networks also influence the overall procurement strategies and market for this compound. In addition, industrial 5-Fluorouracil procurement depends on factors like the cost and steady supply of base materials, compliance with strict production and safety standards, and adherence to environmental rules.
Raw Material for 5-Fluorouracil Production
According to the 5-Fluorouracil production plant project report, the major raw materials for 5-Fluorouracil production include Ethyl Ester of Fluoroacetic Acid-Ethyl Formate and S-methylisothiourea.
Production Process of 5-Fluorouracil
The extensive 5-Fluorouracil production cost report consists of the following industrial production processes:
- Production via Condensation–Cyclization Route: The production process of 5-fluorouracil starts with condensing the ethyl ester of fluoroacetic acid with ethyl formate in the presence of potassium ethoxide to form a reactive hydroxymethylenefluoroacetic ester. Then, this intermediate is cyclised by treating it with S-methylisothiourea, which converts the open-chain ester into a pyrimidine ring and forms 2-methylthio-4-hydroxy-5-fluoropyrimidine. Further, the resulting compound is hydrolysed with hydrochloric acid to remove the methylthio group, which results in the production of 5-fluorouracil as the final product.
5-Fluorouracil is an antimetabolite compound that appears as a white to practically white crystalline powder with no odour. Its molecular formula is C4H3FN2O2, and its molar mass is 130.08 g/mol. The compound has a melting point of about 282–283 degree Celsius, and it does not have a true boiling point because it decomposes when heated further. The density of the compound is around 1.32 g/cm³, and it is sparingly soluble in water while dissolving more readily in alkaline solutions. It is a stable, non-volatile solid, and its IUPAC name is 5-fluoro-1H-pyrimidine-2,4-dione. It is generally handled as a dry crystalline solid and stored in tightly sealed containers to maintain stability.